This inventor holds 1 USPTO granted patent and 5 published patent applications and 4 EPO patents. Top assignee: Immunologik Gmbh. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Ulrich Schubert: Innovator in Retroviral Treatment
Introduction
Ulrich Schubert is a notable inventor based in Munich, Germany. He has made significant contributions to the field of medicine, particularly in the treatment of retroviral infectious diseases. His innovative work has the potential to impact the lives of many individuals affected by such conditions.
Latest Patents
Ulrich Schubert holds a patent for "Agents for the treatment of retroviral infectious diseases." This invention relates to pyridine-3,5-bis-thiocyanates, which are new active substances aimed at treating and preventing retroviral infections, especially HIV infections and AIDS. The compounds he developed act as deubiquitinase inhibitors, enhancing the immunogenicity of viral proteins and thereby boosting the antiviral response.
Career Highlights
Throughout his career, Ulrich Schubert has worked with several companies, including Immunologik GmbH and Metriopharm AG. His experience in these organizations has allowed him to refine his expertise in the field of retroviral treatments and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Christian Setz and Wolfgang Brysch. Their collaborative efforts have further advanced the research and development of innovative treatments for retroviral diseases.
Conclusion
Ulrich Schubert's contributions to the field of retroviral treatment through his patent and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile